AB1161 COVID-19 in my RA clinic: data from questionnaire, vaccination, infection and flares from the RA Louvain Brussels Cohort
(2022) EULAR 2022 European Congress of Rheumatology — Location: (Denmark) Copenhagen (1.June.2022)
Files
16971full.pdf
Open Access - Adobe PDF
- 185.91 KB
Details
- Authors
- Abstract
- (en) BACKGROUND Over 5 million deaths from the COVID-19 disease have been reported in the world. Patients (pts) living with rheumatoid arthritis (RA) affecting the immune system or under immunosuppressive agent are considered as a high risk population for a SARS-CoV-2 infection. Since no antiviral treatment is available, the vaccination is a major option. OBJECTIVES The aim of this study is to evaluate in our RA cohort a questionnaire about the COVID-19 vaccination willingness, to analyse the vaccination rate, the number of COVID infection, the RA flares and the side effects. METHODS We included pts with RA from the UCLouvain Brussels cohort who met the ACR/EULAR 2010 classification criteria. A simple and standard questionnaire about the vaccine willingness was distributed in 2020 before the vaccination. From January to December 21, the rate of vaccination was calculated. The number of Covid infections, RA flares, therapy switches and side effects were also collected. All patient and RA characteristics were analyzed. […]
- Affiliations
Citations
Pirson, V., Sokolova, T., Theunssens, X., Bricman, L., Sapart, E., De Montjoye Stéphanie, Dierckx, S., Avramovska, A., & Durez, P. (2022). AB1161 COVID-19 in my RA clinic: data from questionnaire, vaccination, infection and flares from the RA Louvain Brussels Cohort. Annals of the rheumatic diseases, 81(Suppl 1), 1697. https://doi.org/10.1136/annrheumdis-2022-eular.4393 (Original work published 2022)